Assessment of interleukin-28B (interferon λ3) rs12979860 C/T gene polymorphism and the risk for hepatocellular carcinoma in chronic hepatitis C cirrhotic patients

Salwa H.H. Teama; Sara H.A. Agwa; Osama A.E. El Sayed; Moataz M. Sayed; Aya Abd El Samee; Sarah El Nakeep

doi:10.1097/01.elx.0000515930.52529.6c

Q2 2016

Assessment of interleukin-28B (interferon λ3) rs12979860 C/T gene polymorphism and the risk for hepatocellular carcinoma in chronic hepatitis C cirrhotic patients

Salwa H.H. Teama · Sara H.A. Agwa · Osama A.E. El Sayed · Moataz M. Sayed · Aya Abd El Samee · Sarah El Nakeep

10.1097/01.elx.0000515930.52529.6c 381 Views 2 Citations

Citations

381

Views

Abstract not available for this publication.

Cite this Article (APA)

Salwa, H. T., Sara, H. A., Osama, A. E. S., Moataz, M. S., Aya, A. E. S., Sarah, E. N. (2016). Assessment of interleukin-28B (interferon λ3) rs12979860 C/T gene polymorphism and the risk for hepatocellular carcinoma in chronic hepatitis C cirrhotic patients. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000515930.52529.6c